Adjuvant Immunotherapy Ups Survival in dMMR Colon Cancer
(MedPage Today) -- CHICAGO -- The risk of recurrence or death after surgery for deficient mismatch repair (dMMR) colon cancer ...
(MedPage Today) -- CHICAGO -- The risk of recurrence or death after surgery for deficient mismatch repair (dMMR) colon cancer ...
(MedPage Today) -- CHICAGO -- A structured exercise program improved survival outcomes in patients on adjuvant chemotherapy for colon cancer, ...
(MedPage Today) -- Exhausted, tear-filled eyes met mine the day I met OM*. Shoulders slumped and gazing at his hands, ...
Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), outshone the commonly used selective estrogen ...
(MedPage Today) -- CHICAGO -- Incorporating the investigational, oral selective estrogen receptor degrader (SERD) camizestrant at the first sign of ...
(MedPage Today) -- CHICAGO -- Adding perioperative durvalumab (Imfinzi) to FLOT chemotherapy significantly improved event-free survival (EFS) compared with FLOT ...
Share on Pinterest“Skinny Tok” is an extreme dieting trend on TikTok that equates thinness with health. Miodrag Ignjatovic/Getty Images“Skinny Tok,’ ...
Annabel Rackham and Steven McIntoshCulture reportersBBCRanganathan said he used running, reading and breathing exercises to help centre himself when feeling ...
Getty ImagesRuth CleggHealth and well-being reporterIt's a condition that affects more than 10 million people in the UK. It can ...
The ban on the sale of single-use disposable vapes will come into force on Sunday across the UK, aimed at ...
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/115830 ...
TOPLINEIn patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor ...
(MedPage Today) -- The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who ...
In the treatment of newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), patients who fail to achieve initial molecular ...
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for ...
(MedPage Today) -- I was recently called to jury duty in Washington, D.C. I had no idea what to expect ...
Treatment with pembrolizumab and the antibody-drug conjugate (ADC) sacituzumab govitecan improved progression-free survival (PFS) in patients with PD-L1-positive locally advanced ...
Why is it so hard to understand the effects a warming world has on our health? Source link : https://www.bbc.co.uk/sounds/play/w3ct70s9 ...
(MedPage Today) -- CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line treatment significantly ...
(MedPage Today) -- CHICAGO -- The investigational oral agent vepdegestrant more than doubled median progression-free survival (PFS) versus fulvestrant (Faslodex) ...
© 2022 NewsHealth.
© 2022 NewsHealth.